Definition and management of very high fracture risk in women with postmenopausal osteoporosis: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Association of Bone Assessment and Metabolism (ABRASSO)

Several drugs are available for the treatment of osteoporosis in postmenopausal women. Over the last decades, most patients requiring pharmacological intervention were offered antiresorptive drugs as first-line therapy, while anabolic agents were considered a last resource for those with therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Barbara C., Madeira, Miguel, d’Alva, Catarina Brasil, Maeda, Sergio Setsuo, de Holanda, Narriane Chaves Pereira, Ohe, Monique Nakayama, Szejnfeld, Vera, Zerbini, Cristiano A. F., de Paula, Francisco José Albuquerque, Bandeira, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2022
Materias:
Consensus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118822/
https://www.ncbi.nlm.nih.gov/pubmed/36191263
http://dx.doi.org/10.20945/2359-3997000000522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118822/
https://www.ncbi.nlm.nih.gov/pubmed/36191263
http://dx.doi.org/10.20945/2359-3997000000522

Ejemplares similares